Literature DB >> 23720401

Single-nucleotide polymorphisms in nucleotide excision repair genes, cigarette smoking, and the risk of head and neck cancer.

Annah B Wyss1, Amy H Herring, Christy L Avery, Mark C Weissler, Jeannette T Bensen, Jill S Barnholtz-Sloan, William K Funkhouser, Andrew F Olshan.   

Abstract

BACKGROUND: Cigarette smoking is associated with increased head and neck cancer (HNC) risk. Tobacco-related carcinogens are known to cause bulky DNA adducts. Nucleotide excision repair (NER) genes encode enzymes that remove adducts and may be independently associated with HNC, as well as modifiers of the association between smoking and HNC.
METHODS: Using population-based case-control data from the Carolina Head and Neck Cancer Epidemiology (CHANCE) Study (1,227 cases and 1,325 controls), race-stratified (White, African American), conventional, and hierarchical logistic regression models were used to estimate ORs with 95% intervals (I) for the independent and joint effects of cigarette smoking and 84 single-nucleotide polymorphisms (SNP) from 15 NER genes on HNC risk.
RESULTS: The odds of HNC were elevated among ever cigarette smokers and increased with smoking duration and frequency. Among Whites, rs4150403 on ERCC3 was associated with increased HNC odds (AA+AG vs. GG; OR, 1.28; 95% CI, 1.01-1.61). Among African Americans, rs4253132 on ERCC6 was associated with decreased HNC odds (CC+CT vs. TT; OR, 0.62; 95% CI, 0.45-0.86). Interactions between ever cigarette smoking and three SNPs (rs4253132 on ERCC6, rs2291120 on DDB2, and rs744154 on ERCC4) suggested possible departures from additivity among Whites.
CONCLUSIONS: We did not find associations between some previously studied NER variants and HNC. We did identify new associations between two SNPs and HNC and three suggestive cigarette-SNP interactions to consider in future studies. IMPACT: We conducted one of the most comprehensive evaluations of NER variants, identifying a few SNPs from biologically plausible candidate genes associated with HNC and possibly interacting with cigarette smoking. ©2013 AACR

Entities:  

Mesh:

Year:  2013        PMID: 23720401      PMCID: PMC3766549          DOI: 10.1158/1055-9965.EPI-13-0185

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  60 in total

Review 1.  Polymorphisms in DNA repair genes and associations with cancer risk.

Authors:  Ellen L Goode; Cornelia M Ulrich; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

2.  Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer.

Authors:  Rayjean J Hung; Paul Brennan; Christian Malaveille; Stefano Porru; Francesco Donato; Paolo Boffetta; John S Witte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-06       Impact factor: 4.254

3.  Information on ancestry from genetic markers.

Authors:  Carrie Lynn Pfaff; Jill Barnholtz-Sloan; Jennifer K Wagner; Jeffrey C Long
Journal:  Genet Epidemiol       Date:  2004-05       Impact factor: 2.135

4.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.

Authors:  Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

Review 5.  How nucleotide excision repair protects against cancer.

Authors:  E C Friedberg
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

6.  Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck.

Authors:  Hongxia Ma; Hongping Yu; Zhensheng Liu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Pharmacogenet Genomics       Date:  2012-01       Impact factor: 2.089

7.  Reduced DNA repair capacity in laryngeal cancer subjects. A comparison of phenotypic and genotypic results.

Authors:  Marzena Gajecka; Malgorzata Rydzanicz; Renata Jaskula-Sztul; Martgorzata Wierzbicka; Witold Szyfter; Krzysztof Szyfter
Journal:  Adv Otorhinolaryngol       Date:  2005

8.  Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.

Authors:  H Yuan; Y M Niu; R X Wang; H Z Li; N Chen
Journal:  Genet Mol Res       Date:  2011-11-22

9.  Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.

Authors:  Volker Harth; Martin Schafer; Josef Abel; Laura Maintz; Thomas Neuhaus; Mette Besuden; Robert Primke; Anja Wilkesmann; Ricarda Thier; Hans Vetter; Yon-Dschun Ko; Thomas Bruning; Hermann M Bolt; Katja Ickstadt
Journal:  J Toxicol Environ Health A       Date:  2008

10.  Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population.

Authors:  Amit Kumar Mitra; Neetu Singh; Vivek Kumar Garg; Rashmi Chaturvedi; Mandira Sharma; Srikanta Kumar Rath
Journal:  J Exp Clin Cancer Res       Date:  2009-07-18
View more
  8 in total

1.  Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancer.

Authors:  Douglas R Farquhar; Andrew J Coniglio; Maheer M Masood; Nicholas Lenze; Paul Brennan; Devasena Anantharaman; Behnoush Abedi-Ardekani; Adam M Zanation; Mark C Weissler; Andrew F Olshan; Siddharth Sheth; Trevor G Hackman
Journal:  Oral Oncol       Date:  2020-05-31       Impact factor: 5.337

2.  Single nucleotide polymorphisms in nucleotide excision repair genes, cancer treatment, and head and neck cancer survival.

Authors:  Annah B Wyss; Mark C Weissler; Christy L Avery; Amy H Herring; Jeannette T Bensen; Jill S Barnholtz-Sloan; William K Funkhouser; Andrew F Olshan
Journal:  Cancer Causes Control       Date:  2014-02-02       Impact factor: 2.506

3.  Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents.

Authors:  Gypsyamber D'Souza; Devasena Anantharaman; Tarik Gheit; Behnoush Abedi-Ardekani; Daniel C Beachler; David I Conway; Andrew F Olshan; Victor Wunsch-Filho; Tatiana N Toporcov; Wolfgang Ahrens; Kathy Wisniewski; Franco Merletti; Stefania Boccia; Eloiza H Tajara; Jose P Zevallos; José Eduardo Levi; Mark C Weissler; Sylvia Wright; Ghislaine Scelo; Angela L Mazul; Massimo Tommasino; Gabriella Cadoni; Paul Brennan
Journal:  Oral Oncol       Date:  2016-09-26       Impact factor: 5.337

4.  Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis.

Authors:  Joan Manils; Diana Gómez; Mercè Salla-Martret; Heinz Fischer; Jason M Fye; Elena Marzo; Laura Marruecos; Inma Serrano; Rocío Salgado; Juan P Rodrigo; Juana M Garcia-Pedrero; Anna M Serafin; Xavier Cañas; Carmen Benito; Agustí Toll; Sònia-Vanina Forcales; Fred W Perrino; Leopold Eckhart; Concepció Soler
Journal:  Oncotarget       Date:  2015-09-08

5.  Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer.

Authors:  Gema Bruixola; Javier Caballero; Federica Papaccio; Angelica Petrillo; Aina Iranzo; Miguel Civera; Miriam Moriana; Neus Bosch; Maria Maroñas; Ines González; Miguel Pastor; Andrés Cervantes
Journal:  ESMO Open       Date:  2018-10-24

6.  XAB2 TagSNP Is Associated with the Risk of Gastric Cancer in Chinese Population: A Case-Control Study.

Authors:  Yuning Xie; Yuan Yu; Hongjiao Wu; Hui Gao; Zhenbang Yang; Yi Zhang; Xuemei Zhang
Journal:  Int J Environ Res Public Health       Date:  2021-02-04       Impact factor: 3.390

Review 7.  A review of cancer risk prediction models with genetic variants.

Authors:  Xuexia Wang; Michael J Oldani; Xingwang Zhao; Xiaohui Huang; Dajun Qian
Journal:  Cancer Inform       Date:  2014-09-21

8.  Association between Single-Nucleotide Polymorphism in MicroRNA Target Site of DDB2 and Risk of Hepatocellular Carcinoma in a Southern Chinese Population.

Authors:  Moqin Qiu; Yingchun Liu; Zihan Zhou; Yanji Jiang; Qiuling Lin; Rongrui Huo; Xiumei Liang; Xiangyuan Yu; Xianguo Zhou; Hongping Yu
Journal:  Biomed Res Int       Date:  2020-02-08       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.